GTR 82186915
Bids Are Invited For Price Registration For The Occasional Supply Of Oncological Antineoplastic Medicines (Sei No. 0040609437.000002/2024-10)
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
82186915
Tendering Authority
Subscribe to view
Tender No
1371/2024
Financer Name
Self-Funded
Work Title
Bids Are Invited For Price Registration For The Occasional Supply Of Oncological Antineoplastic Medicines (Sei No. 0040609437.000002/2024-10)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
15-07-2024
Closed
Work Detail
(3547205) - Abiraterone, Acetate - Concentration/Dosage 250 Mg, Tablet Pharmaceutical Form, Oral Administration Route, (3380637) - Zoledronic Acid - Concentration/Dosage 4 Mg, Pharmaceutical Form Lyophilized Powder For Injectable Solution, Vial-Ampule Presentation Form , Intravenous Administration Route, (3108279) - Bleomycin, Sulfate - Concentration/Dosage 15 Iu, Parenteral Administration Route, (3111172) - Carmustine - Concentration/Dosage 100 Mg, (3241416) - Cladribine - Concentration/Dosage 1 Mg/Ml , Pharmaceutical Form Injectable Solution, (3160351) - Chlorambucil - Concentration/Dosage 2 Mg, Pharmaceutical Form Coated Tablet, (3412652) - Cyclophosphamide - Concentration/Dosage 50 Mg, (3106870) - Cyproterone, Acetate - Concentration/Dosage 50 Mg, ( 3242528) - Daunorubicin, Hydrochloride - Concentration/Dosage 20 Mg, Presentation Form Ampoule Vial + Diluent, (3242897) - Fludarabine, Phosphate - Concentration/Dosage 50 Mg, Presentation Form Ampoule Vial + Diluent, (3565033) - Folinate Calcium - Concentration/Dosage 10 Mg/Ml, (3241971) - Idarubicin, Hydrochloride - Concentration/Dosage 10 Mg, (3341127) - Interferon - Type Alpha 2B, Concentration/Dosage 5,000,000 Iu, Subcutaneous Or Intramuscular Administration Route, ( 3372430) - Isotretinoin - Concentration/Dosage 10 Mg, Capsule Pharmaceutical Form, (3093859) - Megestrol, Acetate - Concentration/Dosage 160 Mg, (3184196) - Melphalan - Concentration/Dosage 2 Mg, (3243397) - Mercaptopurine - Concentration/Dosage 50 Mg, (3167119) - Mesna - Concentration/Dosage 400 Mg, (3167984) - Methotrexate - Concentration/Dosage 2.5 Mg, (3242072) - Mitoxantrone - Concentration/Dosage 2 Mg/Ml, (3376346) - Pamidronate Disodium - Concentration/Dosage 90 Mg, (4823478) - Peg-Asparaginase - Concentration/Dosage 750 U/Ml, Pharmaceutical Form Injectable Solution, (3180662) - Rasburicase - Concentration/Dosage 1.5 Mg/Ml, (3246213) - Rituximab - Concentration /Dosage 10 Mg/Ml, (3243346) - Thioguanine - Concentration/Dosage 40 Mg, (3243311) - Tretinoin - Concentration/Dosage 10 Mg, (3198286) - Vinblastine, Sulfate - Concentration/Dosage 10 Mg
Key Value
Tender Value
2,539,731 - BRL
Tender Documents
Global Tender Document
8cb23405-7074-4480-8c76-e10eee3abc94.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.